The Stochastic Oscillator for ALEC moved out of overbought territory on November 12, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 64 similar instances where the indicator exited the overbought zone. In 58 of the 64 cases the stock moved lower. This puts the odds of a downward move at 90%.
The 10-day RSI Indicator for ALEC moved out of overbought territory on November 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator moved out of overbought territory. In 17 of the 20 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALEC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
ALEC broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ALEC entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on ALEC as a result. In 74 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
The Moving Average Convergence Divergence (MACD) for ALEC just turned positive on October 27, 2026. Looking at past instances where ALEC's MACD turned positive, the stock continued to rise in 33 of 39 cases over the following month. The odds of a continued upward trend are 85%.
ALEC moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ALEC crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.
Following a +6.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALEC advanced for three days, in 218 of 260 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-25.646) is normal, around the industry mean (3.498). P/E Ratio (-2.101) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.658) among similar stocks. P/S Ratio (15.060) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. ALEC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALEC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
PRTA broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 35 similar instances where the stock broke above the upper band. In 31 of the 35 cases the stock fell afterwards. This puts the odds of success at 89%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PRTA as a result. In 81 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
The Moving Average Convergence Divergence Histogram (MACD) for PRTA turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 40 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 87%.
PRTA moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRTA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for PRTA entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 58 of 75 cases where PRTA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
Following a +11.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where PRTA advanced for three days, in 202 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.426) is normal, around the industry mean (3.498). P/E Ratio (-9.840) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.658) among similar stocks. P/S Ratio (8.104) is also within normal values, averaging (440.869).
The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 70 (best 1 - 100 worst), indicating slightly worse than average price growth. PRTA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ALEC | PRTA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 6 Undervalued | 15 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 94 | |
PRICE GROWTH RATING 1..100 | 35 | 70 | |
P/E GROWTH RATING 1..100 | 93 | 34 | |
SEASONALITY SCORE 1..100 | 29 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ALEC's Valuation (6) in the Biotechnology industry is in the same range as PRTA (15). This means that ALEC’s stock grew similarly to PRTA’s over the last 12 months.
ALEC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PRTA (100). This means that ALEC’s stock grew similarly to PRTA’s over the last 12 months.
PRTA's SMR Rating (94) in the Biotechnology industry is in the same range as ALEC (100). This means that PRTA’s stock grew similarly to ALEC’s over the last 12 months.
ALEC's Price Growth Rating (35) in the Biotechnology industry is somewhat better than the same rating for PRTA (70). This means that ALEC’s stock grew somewhat faster than PRTA’s over the last 12 months.
PRTA's P/E Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for ALEC (93). This means that PRTA’s stock grew somewhat faster than ALEC’s over the last 12 months.
| ALEC | PRTA | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 85% | N/A |
| Stochastic ODDS (%) | 4 days ago 90% | 4 days ago 77% |
| Momentum ODDS (%) | 4 days ago 76% | 4 days ago 87% |
| MACD ODDS (%) | 4 days ago 85% | 4 days ago 87% |
| TrendWeek ODDS (%) | 4 days ago 83% | 4 days ago 77% |
| TrendMonth ODDS (%) | 4 days ago 80% | 4 days ago 87% |
| Advances ODDS (%) | 6 days ago 84% | 8 days ago 75% |
| Declines ODDS (%) | 14 days ago 87% | 4 days ago 86% |
| BollingerBands ODDS (%) | 4 days ago 84% | 4 days ago 89% |
| Aroon ODDS (%) | 4 days ago 82% | 4 days ago 85% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALEC’s FA Score shows that 1 FA rating(s) are green while PRTA’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALEC’s TA Score shows that 5 TA indicator(s) are bullish while PRTA’s TA Score has 2 bullish TA indicator(s).
ALEC (@Biotechnology) experienced а +10.92% price change this week, while PRTA (@Biotechnology) price change was +2.38% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -3.38%. For the same industry, the average monthly price growth was -5.88%, and the average quarterly price growth was -18.27%.
ALEC is expected to report earnings on Mar 02, 2027.
PRTA is expected to report earnings on Feb 25, 2027.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
A.I.dvisor indicates that over the last year, ALEC has been loosely correlated with EDIT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALEC jumps, then EDIT could also see price increases.
| Ticker / NAME | Correlation To ALEC | 1D Price Change % | ||
|---|---|---|---|---|
| ALEC | 100% | +3.67% | ||
| EDIT - ALEC | 49% Loosely correlated | +1.40% | ||
| BCYC - ALEC | 47% Loosely correlated | -2.32% | ||
| VYGR - ALEC | 43% Loosely correlated | +1.76% | ||
| ARVN - ALEC | 43% Loosely correlated | -0.73% | ||
| PRTA - ALEC | 42% Loosely correlated | -0.85% | ||
More | ||||
A.I.dvisor indicates that over the last year, PRTA has been loosely correlated with MGTX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTA jumps, then MGTX could also see price increases.
| Ticker / NAME | Correlation To PRTA | 1D Price Change % | ||
|---|---|---|---|---|
| PRTA | 100% | -0.85% | ||
| MGTX - PRTA | 47% Loosely correlated | +4.44% | ||
| EDIT - PRTA | 47% Loosely correlated | +1.40% | ||
| CRSP - PRTA | 44% Loosely correlated | -0.89% | ||
| ARVN - PRTA | 44% Loosely correlated | -0.73% | ||
| VYGR - PRTA | 43% Loosely correlated | +1.76% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| CRYPTO / NAME | Price $ | Chg $ | Chg % |
| BOND.X | 0.011508 | 0.002628 | +29.59% |
| BarnBridge cryptocurrency | |||
| QNT.X | 156.780320 | 13.548920 | +9.46% |
| Quant cryptocurrency | |||
| FTT.X | 0.205185 | 0.011240 | +5.80% |
| FTX Token cryptocurrency | |||
| FLUX.X | 0.047694 | 0.002173 | +4.77% |
| Flux cryptocurrency | |||
| WRX.X | 0.016320 | -0.000320 | -1.92% |
| WazirX cryptocurrency | |||